I got a full panel before starting and a repeat at three months, and the second one is more useful than the first purely because I now have something to compare against.
The question I want answered is how often to repeat it, because quarterly seems to be the convention and I cannot find the reasoning.
I would rather have one careful answer than five confident ones.
This one has a reasonably settled answer, so here it is. A defensible baseline is short: HbA1c and fasting glucose, a lipid panel with ApoB if you can get it, ALT and AST, creatinine with eGFR, TSH, ferritin and B12, and a full blood count. That set catches the things that change, the things that explain symptoms, and the things that alter the prescribing decision. Almost everything else on the long circulating lists is either invariant, uninterpretable without a specific question, or an incidental finding waiting to cause an unnecessary workup.
Ask again with the specifics and you will get a better answer than this one.
NurseKim_ATL said:A defensible baseline is short: HbA1c and fasting glucose, a lipid panel with ApoB if you can get it, ALT and AST, creatinine with eGFR, TSH, ferritin…
No disagreement with NurseKim_ATL. One condition attached. One addition: if the lab changes analytical platform between your draws, the comparison breaks and nobody tells you. It is worth asking when a value moves inexplicably.
Happy to go further on any of that.
PeptideDetective — Independent Peptide Analytics
Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.
View Resultspete_manc_UK said:I got a full panel before starting and a repeat at three months, and the second one is more useful than the first purely because I now have something…
Can confirm the pattern pete_manc_UK describes. The single most useful discipline is bringing the whole panel to a clinician rather than one flagged value. One out-of-range result in isolation generates anxiety and unnecessary tests; the same result next to the trend and the rest of the panel usually generates a shrug.
From the other side of the consultation, briefly.
Shot day Wednesday report relevant to baseline bloodwork:
Week 25. Currently on 15mg. Down 31 lbs from starting weight of 243 lbs.
This week's observations: Mild fatigue day 1-2 post-injection, then fine.
Labs due next week — looking forward to seeing the metabolic panel. I'll post results in the Lab Results section when they come in.